Search result for biotech
Beginning on June 1, Germany will accept COVAXIN from Bharat Biotech for use in travel
The WHO-listed COVID vaccination COVAXIN from Bharat Biotech has been approved by the German government for use beginning on June 1 in travel to India, according to Walter J Lindner, the German ambassador to India. In November of last year, the World Health Organization (WHO) added COVAXIN to its...
Global Marine Biotechnology Market was Worth US$ 1.2 Bn in 2021 and is Expected to Reach CAGR of 7% over the forecast period
Most of the answers for our questions lie in the nature. As all living creatures exists in one eco system, they are completely dependent on each other and this remains true in the case of marine life. The ocean is full of possibilities and yet the humans are unable to tap its full potential...
UAE Increasing Research and Diagnostics
AstraZeneca, a leading British-Swedish biotechnology company has announced its partnership with G42 Healthcare, an artificial intelligence and cloud computing company in Abu Dhabi. The partnership aims at exploring real-world evidence and conducting clinical trials using the Insights Research Org...
U.S. Action on China for Abusing Biotechnology
On Thursday, the Bureau of Industry and Security of the US Commerce Department announced a trade ban on 34 research institutes and entities of China including its Academy of Military Medical Sciences over claims of using biotechnology for abusing human rights and in military applications.
...
BHARAT BIOTECH TO SELL COVAXIN IN CANADA WITH THE HELP OF OCUGEN
Highlights
• The two companies have already signed an agreement to sell Covaxin in the United States
Indian biotechnology company Bharat Biotech that had developed Covid-19 vaccine Covaxin is now planning to sell it in the country of Canada with Bharat Biotech with the he...
OCUGEN, BHARAT BIOTECH'S AMERICAN PARTNER SUBMITS MASTER FILE ON COVAXIN TO THE US FDA
Highlights
• Ocugen has submitted a "Master File" to the US Food and Drug Administration before seeking an emergency use authorisation (EUA) in the United States
• The Bharat Biotech told the government of India that it has already submitted 90% of document...
BHARAT BIOTECH FILES FOR EMERGENCY USE LISTING FOR COVAXIN
Highlights
• Bharat Biotech told Indian government that the remaining documents are most likely to be submitted by June
• The vaccine developed by the Hyderabad-based company has already received regulatory approval from 11 countries
According to the source...
INDIAN GOVERNMENT FIRMS PREPARE TO MANUFACTURE COVAXIN
HIGHLIGHTS
- Indian Government firms are preparing to manufacture Covaxin.
- Covaxin was first developed with seed strains received from the National Institute of Virology (NIV).
- Phase 3 clinical trial of Covaxin was co-funded by ICMR. <...
INDIA’S COVAXIN NEUTRALISES 617 VARIANTS OF COVID-19 SAYS DR. ANTHONY FAUCI
Highlights
• COVAXIN has been developed by Bharat Biotech in partnership with National Institute of Virology and the Indian Council of Medical Research
• Dr. Fauci said "So, despite the real difficulty that we're seeing in India, vaccination could be a...
CHINA DEVELOPED mRNA VACCINE LIKELY TO START TRIALS NEXT MONTH
Highlights –
- China developed mRNA vaccine likely to start trials next month.
- The vaccine candidate ARCoV is said to be the furthest along the clinical trial process at present.
- The vaccine may get overseas approval to conduct Phase II...
CHINA PLANS TO BOOST COVID-19 VACCINE EFFICACY RATE BY MIXING IT
Highlights –
- China plans to boost COVID-19 vaccine efficacy rate by mixing it.
- Gao Fu says that giving people doses of different vaccines is one way to improve vaccines.
- China has developed four domestic vaccines approved for public u...
BHARAT BIOTECH AND CSIR COLLABORATING TO MAKE RAW MATERIAL FOR VACCINES
HIGHLIGHTS
- India is importing adjuvants and other chemicals for vaccine manufacturing.
- Preservatives for vaccines have been imported from Germany.
- Some raw material has also been imported from the USA.
Hyderabad-based Bhar...
JAPAN’S DAIICHII BIOTECH STARTS MANUFCATURING ASTRAZENECA’S COVID-19 VACCINE
Highlights –
- Japan’s Daiichi Biotech starts manufacturing AstraZeneca’s COVID-19 vaccine.
- The Japanese drugmaker has begun manufacturing the vaccine based on an outsourcing agreement.
- The vaccine will be supplied after gai...
MICROBIOME BIOTECH FIRM GENOME & COMPANY AWAIT FINAL WORD BEFORE IPO ON KOSDAQ
- Still waiting to go public with its initial public offering (IPO) at tech-intensive KOSDAQ later this year, Genome & Company laid out the biotech firm's various business models and oncoming visions focusing on its microbiome-based immuno-oncology expertise at its IR event on Thurs...
KOREAN BIOTECH AND WELLNESS COMPANIES TO INFUSE 10 TRILLION WON BY 2023
- Korea’s chief biotech and wellness companies, including Samsung Biologics and Celltrion, will pour funds to the tune of 10 trillion won by 2023.
- The Ministry of Trade, Industry and Energy announced its innate tactics to foster the biotech and healthcare industry and bolst...
SOUTH KOREA’S GL RAPHA TO PRODUCE 150 MILLION VIALS OF RUSSIAN COVID-19 VACCINE
- Bio-tech Company GL Rapha has been chosen to produce 150 million doses of Russia's Sputnik V vaccine to battle against the COVID-19 in Korea every year, the Russian Direct Investment Fund (RDIF) said Friday.
- The statement was issued after the RDIF declared in August that Ru...
CHINA’S COVID-19 VACCINES ON DISPLAY AFTER SOME HULLABALOO
- China has showcased its homegrown coronavirus vaccines for the first time, as the country where the contagion originated looks to bring some semblance to the narrative surrounding the pandemic.
- High hopes dangle on the small encased droplets of liquid put on show at a Beijing t...
STARTUP COMPANY BONAC CORP. TO START HUMAN CLINICAL TRIAL FOR A COVID-19 DRUG IN 2021
Highlights –
- Startup company Bonac Corp. to start human clinical trial for a COVID-19 drug in 2021.
- The startup company is based in Kurume, Fukuoka Prefecture.
- The company has currently developed 72 possible COVID-19 drug candidates ...
BHARAT BIOTECH GETS DCGI APPROVAL TO CONDUCT COVAXIN TEST THROUGH SKIN
Highlights
• According to the reports, the approval from the DCGI is subject to two conditions
• It is stated that if these clinical trials are successful, the vaccine will be available at a cheaper cost
• Union Minister Dr Harsh Vardhan said if everyt...
COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO BEGIN PHASE 2 TRIALS OF OXFORD VACCINE THIS WEEK
Highlights
• The Serum Institute of India has stated that it has shortlisted 10 centres across the nation to conduct Phase II and Phase III human clinical trials of COVID-19 vaccine developed by the University of Oxford
• On Monday, the national expert group on vacci...